Primary Results From The Phase 3 Shine Study Of Ibrutinib In Combination With Bendamustine-Rituximab (Br) And R Maintenance As A First-Line Treatment For Older Patients With Mantle-Cell Lymphoma
Bendamustine;Ibrutinib;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Primary Results From The Phase 3 Shine Study Of Ibrutinib In Combination With Bendamustine-Rituximab (Br) And R Maintenance As A First-Line Treatment For Older Patients With Mantle-Cell Lymphoma ### Output: Bendamustine;Ibrutinib;Rituximab